263 related articles for article (PubMed ID: 1339083)
21. Determinants of the variability of aflatoxin-albumin adduct levels in Ghanaians.
Dash B; Afriyie-Gyawu E; Huebner HJ; Porter W; Wang JS; Jolly PE; Phillips TD
J Toxicol Environ Health A; 2007 Jan; 70(1):58-66. PubMed ID: 17162498
[TBL] [Abstract][Full Text] [Related]
22. [Hepatocellular carcinoma: a preventable cancer].
Viviani S; Jack A; Bah E; Montesano R
Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
[TBL] [Abstract][Full Text] [Related]
23. Quantitative comparison of aflatoxin B1 serum albumin adducts in humans by isotope dilution mass spectrometry and ELISA.
Scholl PF; Turner PC; Sutcliffe AE; Sylla A; Diallo MS; Friesen MD; Groopman JD; Wild CP
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):823-6. PubMed ID: 16614131
[TBL] [Abstract][Full Text] [Related]
24. Aflatoxin-albumin adducts and correlation with decreased serum levels of vitamins A and E in an adult Ghanaian population.
Tang L; Xu L; Afriyie-Gyawu E; Liu W; Wang P; Tang Y; Wang Z; Huebner HJ; Ankrah NA; Ofori-Adjei D; Williams JH; Wang JS; Phillips TD
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2009 Jan; 26(1):108-18. PubMed ID: 19680878
[TBL] [Abstract][Full Text] [Related]
25. Aflatoxin exposure in Singapore: blood aflatoxin levels in normal subjects, hepatitis B virus carriers and primary hepatocellular carcinoma patients.
Chao TC; Lo DS; Bloodworth BC; Gunasegaram R; Koh TH; Ng HS
Med Sci Law; 1994 Oct; 34(4):289-98. PubMed ID: 7830511
[TBL] [Abstract][Full Text] [Related]
26. Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study.
Abdel-Wahab M; Mostafa M; Sabry M; el-Farrash M; Yousef T
Hepatogastroenterology; 2008; 55(86-87):1754-9. PubMed ID: 19102385
[TBL] [Abstract][Full Text] [Related]
27. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
[TBL] [Abstract][Full Text] [Related]
28. [Epidemiology of malignant liver tumors].
Rodella S; Picoco C
Ann Ist Super Sanita; 1996; 32(4):595-610. PubMed ID: 9382428
[TBL] [Abstract][Full Text] [Related]
29. Aflatoxin as a cause of primary liver-cell cancer in the United States: a probability study.
Stoloff L
Nutr Cancer; 1983; 5(3-4):165-86. PubMed ID: 6322137
[TBL] [Abstract][Full Text] [Related]
30. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan.
Yu MW; Lien JP; Chiu YH; Santella RM; Liaw YF; Chen CJ
J Hepatol; 1997 Aug; 27(2):320-30. PubMed ID: 9288607
[TBL] [Abstract][Full Text] [Related]
31. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC
Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179
[TBL] [Abstract][Full Text] [Related]
32. Correlation of dietary aflatoxin B1 levels with excretion of aflatoxin M1 in human urine.
Zhu JQ; Zhang LS; Hu X; Xiao Y; Chen JS; Xu YC; Fremy J; Chu FS
Cancer Res; 1987 Apr; 47(7):1848-52. PubMed ID: 3102051
[TBL] [Abstract][Full Text] [Related]
33. NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine.
Wang P; Afriyie-Gyawu E; Tang Y; Johnson NM; Xu L; Tang L; Huebner HJ; Ankrah NA; Ofori-Adjei D; Ellis W; Jolly PE; Williams JH; Wang JS; Phillips TD
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 May; 25(5):622-34. PubMed ID: 18478481
[TBL] [Abstract][Full Text] [Related]
34. Aflatoxin and liver cancer in Sudan.
Omer RE; Bakker MI; van't Veer P; Hoogenboom RL; Polman TH; Alink GM; Idris MO; Kadaru AM; Kok FJ
Nutr Cancer; 1998; 32(3):174-80. PubMed ID: 10050268
[TBL] [Abstract][Full Text] [Related]
35. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan.
Wang LY; Hatch M; Chen CJ; Levin B; You SL; Lu SN; Wu MH; Wu WP; Wang LW; Wang Q; Huang GT; Yang PM; Lee HS; Santella RM
Int J Cancer; 1996 Sep; 67(5):620-5. PubMed ID: 8782648
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China.
Yeh FS; Yu MC; Mo CC; Luo S; Tong MJ; Henderson BE
Cancer Res; 1989 May; 49(9):2506-9. PubMed ID: 2539905
[TBL] [Abstract][Full Text] [Related]
37. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
[TBL] [Abstract][Full Text] [Related]
38. [Detection of aflatoxin-albumin adducts in human serum and its application].
Sun G; He X; Qian G; Pu Y
Wei Sheng Yan Jiu; 2001 May; 30(3):185-8. PubMed ID: 12525098
[TBL] [Abstract][Full Text] [Related]
39. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
[TBL] [Abstract][Full Text] [Related]
40. Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children.
Allen SJ; Wild CP; Wheeler JG; Riley EM; Montesano R; Bennett S; Whittle HC; Hall AJ; Greenwood BM
Trans R Soc Trop Med Hyg; 1992; 86(4):426-30. PubMed ID: 1440826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
